UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug
As COVID-19 infection rates and death tolls continue to rise, researchers and…
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.